Wei-Yin Kuo

Dr. Wei-Yin Kuo


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
WKWei-Yin Kuo
Wei-Yin Kuo
HHHan-Sheng Hsu
Han-Sheng Hsu
PKPei-Tseng Kung
Pei-Tseng Kung
WTWen-Chen Tsai
Wen-Chen Tsai
This study examined the impact of socioeconomic status on colorectal cancer risk, staging, and survival under the National Health Insurance (NHI) system in Taiwan. Monthly salary and education level were used as measures of socioeconomic status to observe the risk of colorectal cancer among individuals aged 40 years or above in 2006–2015 and survival outcomes of patients with colorectal cancer until the end of 2016. Data from 286,792 individuals were used in this study. Individuals with a monthly salary ≤Q1 were at a significantly lower incidence risk of colorectal cancer than those with a monthly salary >Q3 (HR = 0.80, 95% CI = 0.74–0.85), while those with elementary or lower education were at a significantly higher risk than those with junior college, university, or higher education (HR = 1.18, 95% CI = 1.06–1.31). The results show that socioeconomic status had no significant impact on colorectal cancer stage at diagnosis. Although salary was not associated with their risk of mortality, patients with colorectal cancer who had elementary or lower education incurred a significantly higher risk of mortality than those who had junior college, university, or higher education (HR = 1.39, 95% CI = 1.07–1.77). Education level is a significant determinant of the incidence risk and survival in patients with colorectal cancer, but only income significantly impacts incidence risk.

16 October 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
WKWei-Yin Kuo
Wei-Yin Kuo
WTWen-Chen Tsai
Wen-Chen Tsai
PKPei-Tseng Kung
Pei-Tseng Kung
Objectives: This study’s objectives were to compare the participation rates of people with and without disabilities who had type 2 diabetes in a diabetes pay-for-performance (DM P4P) program, as well as their care outcomes after participation. Methods: This was a retrospective cohort study. The data came from the disability registry file, cause of death file, and national health insurance research database of Taiwan. The subjects included patients newly diagnosed with type 2 diabetes between 2001 and 2013 who were followed up with until 2014 and categorized as disabled and non-disabled patients. The propensity score matching method was used to match the disabled with the non-disabled patients at a 1:1 ratio. Conditional logistic regression analysis was used to determine the odds ratio between the disabled and non-disabled patients who joined the P4P program. The Cox hazard model was used to compare the risk of dialysis and death between the disabled and non-disabled patients participating in the P4P program. Results: There were 110,645 disabled and 110,645 non-disabled individuals after matching. After controlling for confounding factors, it was found that the disabled individuals were significantly less likely (odds ratio = 0.89) to be enrolled in the P4P program than the non-disabled individuals. The risk of dialysis was 1.08 times higher for people with disabilities than those without, regardless of their participation in the P4P program. After enrollment in the P4P program, the risk of death for people with disabilities decreased from 1.32 to 1.16 times that of persons without disabilities. Among the people with disabilities, the risk of death for those enrolled in the P4P program was 0.41 times higher than that of those not enrolled. The risk of death was reduced to a greater extent for people with disabilities than for those without disabilities upon enrollment in the DM P4P program. Conclusion: People with disabilities are less likely to be enrolled in the P4P program in Taiwan and have unequal access to care. However, the P4P program was more effective at reducing mortality among people with disabilities than among those without.

25 May 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
CLChun-Ming Liao
Chun-Ming Liao
CCChia-Yu Chen
Chia-Yu Chen
PKPei-Tseng Kung
Pei-Tseng Kung
WKWei-Yin Kuo
Wei-Yin Kuo
HCHui-Chuan Chuang
Hui-Chuan Chuang
WTWen-Chen Tsai
Wen-Chen Tsai
Despite the global decline in the standardized mortality rate of multiple sclerosis (MS), recent research on MS patient survival, especially in Taiwan, remains limited. This study aimed to investigate survival, mortality causes, and associated factors among MS patients in Taiwan. The Taiwan National Health Insurance Research Database was used as the primary data source, and a Cox proportional hazard model was employed to estimate and analyze factors related to survival. We analyzed data from 1444 MS patients diagnosed between 2000 and 2018. Age at diagnosis was positively correlated with the risk of death. Among the 190 patients who died, the leading causes of disease-related deaths were nervous system diseases (n = 83, 43.68%), followed by respiratory system diseases and certain infectious and parasitic diseases. The 8-, 13-, and 18-year survival rates for MS patients were 0.97, 0.91, and 0.81, respectively. This study highlights that the MS patient’s socioeconomic status, environmental factors, comorbidity severity, and related medical variables were not significantly associated with survival.

13 November 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
TLTa-Jen Liu
Ta-Jen Liu
WKWei-Yin Kuo
Wei-Yin Kuo
YLYou-Chen Lin
You-Chen Lin
PKPei-Tseng Kung
Pei-Tseng Kung
WTWen-Chen Tsai
Wen-Chen Tsai
Background: During the COVID-19 pandemic, patients’ willingness to seek medical attention decreased. Patients with precancerous lesions may have missed out on opportunities for early detection. This affected the time to the initiation of treatment for patients with oral cancer. This study examined whether patients with oral cancer were less likely to be at early cancer stages and analyzed whether the time from the diagnosis to the initiation of treatment was delayed during the pandemic. Methods: This retrospective study analyzed data from the Taiwan National Health Insurance Research Database, Cancer Registry File, and Multiple Cause of Death File. Patients who received new diagnoses of oral cancer were divided into a pre-COVID-19 group (2018) and an early COVID-19 group (2020). Propensity score matching was performed between the two cohorts. Conditional logistic regression analyses were conducted to evaluate the risks of an early-stage oral cancer diagnosis and treatment delay from diagnosis to treatment initiation in the two periods. Results: The odds ratio (OR) for early cancer staging among patients with oral cancer in the early COVID-19 period was 0.89 (95% CI: 0.82–0.96) compared to the pre-COVID-19 period. The OR for delayed treatment among patients with oral cancer in the early COVID-19 period compared with that in the pre-COVID-19 period was 0.95 (95% CI: 0.86–1.05; p = 0.337). Conclusions: The early COVID-19 period was associated with a higher risk of advanced cancer staging, and we did not find a significant association with a delay in the initiation of treatment among patients with oral cancer in Taiwan.

23 July 2021 in Research Square
Verified
Preprint
Open access
PDF file
CLChin-Jung Liu
Chin-Jung Liu
YCYeong-Ruey Chu
Yeong-Ruey Chu
CCChia-Chen Chu
Chia-Chen Chu
PKPei-Tseng Kung
Pei-Tseng Kung
WKWei-Yin Kuo
Wei-Yin Kuo
WTWen-Chen Tsai
Wen-Chen Tsai
Background: Several studies have shown that hospice palliative care interventions for cancer patients can reduce medical utilisation. In Taiwan, 20–25% of mechanical ventilation patients have been on prolonged mechanical ventilation (PMV), but only a few studies have discussed the effectiveness of hospice palliative care on these patients. This study aimed to explore the effectiveness of medical utilisation on patients undergoing PMV in hospice palliative care.Methods: From the Health Insurance database of a nationwide population-based study, we identified patients who had been on mechanical ventilation for over 21 days, were 18 years or older between 2009 to 2017, and had undergone hospice palliative care. The control group was obtained by 1:1 matching using propensity scoring after excluding patients who had participated in palliative care for less than 15 or more than 181 days. Furthermore, we used conditional logistic regression analysis to explore intensive care unit readmission, emergency department presentation, and cardiopulmonary resuscitation incidents, 14 days prior to death.Results: A total of 186,533 new PMV patients aged ≥ 18 years with terminal diseases were admitted between 2009 and 2017. Additionally, the number of patients receiving palliative care increased annually, from 0.6% in 2009 to 41.33% in 2017. The number of prolonged mechanical ventilation during emergency visits (odds ratio [OR]=0.68, 95%CI: 0.63-0.74), intensive care unit hospitalisation (OR=0.59, 95%CI: 0.53-0.46), cardiopulmonary resuscitation (OR=0.40, 95%CI: 0.35-0.46), and total hospitalisation cost (USD 1319.9.57 ± 1821.67 vs. 1544.37 ± 2309.27) was lower in the palliative care group.Conclusion: Patients undergoing PMV whilst in hospice palliative care can significantly reduce total hospitalisation cost, intensive care unit admittance, cardiopulmonary resuscitation utilisation, and medical expenses at ≤14 days prior to death.